CNN’s Elizabeth Cohen spoke with with Dawn Baker, the first person in the US to get a shot of Moderna’s investigational vaccine in a Phase 3 trial. Moderna is developing it with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
CNN’s Elizabeth Cohen spoke with with Dawn Baker, the first person in the US to get a shot of Moderna’s investigational vaccine in a Phase 3 trial. Moderna is developing it with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
